Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $919.29 | 51 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $799.39 | 46 | $0 (2024) |
| Janssen Biotech, Inc. | $76.04 | 3 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $43.86 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $230.29 | 13 | ABBVIE INC. ($186.43) |
| 2023 | $245.87 | 14 | ABBVIE INC. ($219.93) |
| 2022 | $259.57 | 14 | ABBVIE INC. ($233.54) |
| 2021 | $183.56 | 10 | AbbVie Inc. ($159.49) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $2.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Gastroenterology | ||||||
| 09/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: IMMUNOLOGY | ||||||
| 08/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.96 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: IMMUNOLOGY | ||||||
| 03/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Gastroenterology | ||||||
| 12/01/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/29/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/20/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: Immunology | ||||||
| 10/18/2023 | ABBVIE INC. | LINZESS (Drug), CREON, VIBERZI | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/27/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.59 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/28/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: IMMUNOLOGY | ||||||
| 04/07/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: IMMUNOLOGY | ||||||
| 03/13/2023 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 86 | 100 | $13,926 | $4,072 |
| 2022 | 2 | 79 | 87 | $12,096 | $4,152 |
| 2021 | 2 | 76 | 87 | $12,387 | $3,788 |
| 2020 | 2 | 62 | 74 | $11,602 | $2,737 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 73 | 86 | $11,112 | $3,228 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 14 | $2,814 | $843.84 | 30.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 52 | 57 | $6,514 | $2,199 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 30 | $5,582 | $1,953 | 35.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 39 | $7,059 | $2,180 | 30.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 41 | 48 | $5,328 | $1,609 | 30.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 42 | 52 | $9,204 | $2,054 | 22.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 20 | 22 | $2,398 | $682.69 | 28.5% |
About Deon Case
Deon Case is a Clinic/Center healthcare provider based in Weston, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2017. The National Provider Identifier (NPI) number assigned to this provider is 1932648995.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Deon Case has received a total of $919.29 in payments from pharmaceutical and medical device companies, with $230.29 received in 2024. These payments were reported across 51 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($919.29).
As a Medicare-enrolled provider, Case has provided services to 303 Medicare beneficiaries, totaling 348 services with total Medicare billing of $14,749. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Clinic/Center
- Other Specialties Family
- Location Weston, FL
- Active Since 02/22/2017
- Last Updated 11/24/2020
- Taxonomy Code 261Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1932648995
Products in Payments
- RINVOQ (Biological) $311.21
- HUMIRA (Biological) $218.80
- SKYRIZI (Biological) $106.36
- STELARA (Biological) $76.04
- VIBERZI (Drug) $57.76
- CREON (Drug) $45.84
- XIFAXAN (Drug) $43.86
- LINZESS (Drug) $38.41
- MAVYRET (Drug) $21.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.